Michael R. Freund MD is currently a senior staff general and colorectal surgeon at Shaare Zedek Medical Center in Jerusalem, Israel. He has previously trained at the Mount Sinai Hospital in NYC and completed his fellowship in minimally invasive colorectal surgery at Cleveland Clinic Florida. He currently holds the position of Senior Lecturer at the Hebrew University faculty of medicine. His research focuses mainly on the surgical treatment of IBD, colon, and rectal cancer.
Selected publications from PubMed
Intraoperative Systemic Chemotherapy in Stage II-III Appendiceal Adenocarcinoma: A National Cancer Database Analysis.
Perets M, Kahana N, Freund MR, Horesh N, Al Khaldi M, Bayat Z, Boutros M, Emile SH
J Gastrointest Cancer. 2026 Sep 3;57(1) pii: 210. doi: 10.1007/s12029-026-01587-8.
National Trends in the Use of Palliative Therapy in Stage IV Rectal Cancer in the United States.
Perets M, Kahana N, Freund MR, Horesh N, Al Khaldi M, Bayat Z, Emile SH
J Surg Oncol. 2026 Sep;134(4):564-573 doi: 10.1002/jso.70322.
[Robotic Colorectal Surgery in Israel - An Institutional Learning Curve and a Glance to the Future].
Anuka E, Amara M, Reissman P, Freund MR
Harefuah. 2026 Mar;165(3):159-163.
Neoadjuvant chemotherapy improves overall survival in stage III but not in stage II colon cancer: A propensity score-matched analysis of the National Cancer Database.
Horesh N, Emile SH, Freund MR, Garoufalia Z, Gefen R, Zhou P, Nagarajan A, Wexner SD
Surgery. 2025 Jul;183:109389 doi: 10.1016/j.surg.2025.109389.
Comparing answers of ChatGPT and Google Gemini to common questions on benign anal conditions.
Maron CM, Emile SH, Horesh N, Freund MR, Pellino G, Wexner SD
Tech Coloproctol. 2025 Jan 26;29(1):57 doi: 10.1007/s10151-024-03096-x.
Help your network discover Dr. Michael Freund's clinical expertise.
